✦ LIBER ✦

Ribavirin/interferon α-2b (IFN) therapy is very effective in the treatment of chronic hepatitis C genotype 2&3 patients who have failed to respond virologically to IFN monotherapy

✍ Scribed by Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Powell, Jerry S.; Saicheur, Theparat; Sheykhzadeh, Paul I.; Yu, Andy S.

Book ID: 124106113
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 188 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81900-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribavirin/interferon alpha-2b therapy is

Ribavirin/interferon alpha-2b therapy is very effective in the treatment of chronic hepatitis C genotype 2 & 3 patients who have failed to respond virologically to interferon monotherapy

✍ Neville Pimstone; Paul Sheykhzadeh; John Canio; Michelle Chiang; Jerry Powell; J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Re-treatment virologic response in chron

Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy)

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Interferon-alfacon-1 shows efficacy in p

Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN-α-2b plus ribavirin

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

PEG-interfeoon α-2b + ribavirin for trea

PEG-interfeoon α-2b + ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b + ribavirin therapy

✍ Sulkowski, Mark; Rothstein, Ken; Stein, Lawrence; Godofsky, Elliot; Goodman, Rus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

PEG-interferon α-2b plus ribavirin for t

PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon α or interferon α-2b plus ribavirin therapy: Mark Sulkowski, Johns Hopkins Medical Institutions, Baltimore, MD; Kenneth D Rothstein, Albert Einstein Medical Ctr, Philadelphia, PA; Lawrence Stein, Florham Park, New Jersey, Florham Park, NJ; Eliot Godofsky, Bradenton, Florida, Bradenton, FL; David Shoultz, PPD Development and University of Washington, Seattle, WA; Russ Hudnall, Mary Huff, Hepatitis Resource Network, Tacoma, WA; Douglas Dieterich, New York University School of Medicine, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB